SunBio,Inc. (KOSDAQ:067370)

Market Cap	69.02B -28.3%
Revenue (ttm)	2.17B +2.3%
Net Income	1.39B
EPS	249.33
Shares Out	12.19M
PE Ratio	22.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,972
Open	6,610.00
Previous Close	6,650.00
Day's Range	6,210.00 - 6,610.00
52-Week Range	4,840.00 - 8,500.00
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 067370